News
After 15 years leading the charity, Steve Ford is saying a fond farewell to Parkinson's UK at the end of January 2021. He'll then start his search for a new challenge.
Find out about a parliamentary committee we gave evidence to about the impact of coronavirus on people with Parkinson’s
We're funding a new research study into a possible treatment for hallucinations in Parkinson's.
Parkinson's UK supporter Paul Mayhew-Archer reflects on his MBE in the honours list.
Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.
Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.
Sharing the results of the 'What Matters Most?' survey and coronavirus poll that have determined our campaigning priorities for the next four years
Our in person events and activities have been on hold since March. We're taking a phased approach to starting them back up.
Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.